nodes	percent_of_prediction	percent_of_DWPC	metapath
Diatrizoate—Extravasation—Carboplatin—esophageal cancer	0.0432	0.0432	CcSEcCtD
Diatrizoate—Memory loss—Cisplatin—esophageal cancer	0.0376	0.0376	CcSEcCtD
Diatrizoate—Skin necrosis—Cisplatin—esophageal cancer	0.0317	0.0317	CcSEcCtD
Diatrizoate—Infarction—Capecitabine—esophageal cancer	0.0294	0.0294	CcSEcCtD
Diatrizoate—Speech impairment NOS—Methotrexate—esophageal cancer	0.0278	0.0278	CcSEcCtD
Diatrizoate—Vasospasm—Capecitabine—esophageal cancer	0.0239	0.0239	CcSEcCtD
Diatrizoate—Anuria—Methotrexate—esophageal cancer	0.0174	0.0174	CcSEcCtD
Diatrizoate—Skin necrosis—Methotrexate—esophageal cancer	0.0174	0.0174	CcSEcCtD
Diatrizoate—Sneezing—Capecitabine—esophageal cancer	0.0147	0.0147	CcSEcCtD
Diatrizoate—Necrosis—Cisplatin—esophageal cancer	0.0141	0.0141	CcSEcCtD
Diatrizoate—Infection—Carboplatin—esophageal cancer	0.0134	0.0134	CcSEcCtD
Diatrizoate—Haematoma—Capecitabine—esophageal cancer	0.013	0.013	CcSEcCtD
Diatrizoate—Respiratory distress—Capecitabine—esophageal cancer	0.0128	0.0128	CcSEcCtD
Diatrizoate—Nephropathy—Methotrexate—esophageal cancer	0.0128	0.0128	CcSEcCtD
Diatrizoate—Extravasation—Cisplatin—esophageal cancer	0.0127	0.0127	CcSEcCtD
Diatrizoate—Thrombosis—Capecitabine—esophageal cancer	0.0115	0.0115	CcSEcCtD
Diatrizoate—Pain—Carboplatin—esophageal cancer	0.0115	0.0115	CcSEcCtD
Diatrizoate—Azotaemia—Methotrexate—esophageal cancer	0.0114	0.0114	CcSEcCtD
Diatrizoate—Wheezing—Cisplatin—esophageal cancer	0.0107	0.0107	CcSEcCtD
Diatrizoate—Ventricular fibrillation—Capecitabine—esophageal cancer	0.0107	0.0107	CcSEcCtD
Diatrizoate—Body temperature increased—Carboplatin—esophageal cancer	0.0106	0.0106	CcSEcCtD
Diatrizoate—Skin exfoliation—Cisplatin—esophageal cancer	0.0106	0.0106	CcSEcCtD
Diatrizoate—Injection site pain—Capecitabine—esophageal cancer	0.00999	0.00999	CcSEcCtD
Diatrizoate—Petechiae—Capecitabine—esophageal cancer	0.00991	0.00991	CcSEcCtD
Diatrizoate—Eruption—Methotrexate—esophageal cancer	0.00987	0.00987	CcSEcCtD
Diatrizoate—Eye irritation—Capecitabine—esophageal cancer	0.00955	0.00955	CcSEcCtD
Diatrizoate—Lacrimation increased—Capecitabine—esophageal cancer	0.00885	0.00885	CcSEcCtD
Diatrizoate—Paralysis—Methotrexate—esophageal cancer	0.00874	0.00874	CcSEcCtD
Diatrizoate—Renal failure acute—Cisplatin—esophageal cancer	0.0087	0.0087	CcSEcCtD
Diatrizoate—Cyanosis—Methotrexate—esophageal cancer	0.00858	0.00858	CcSEcCtD
Diatrizoate—Amnesia—Cisplatin—esophageal cancer	0.00855	0.00855	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.0083	0.0083	CcSEcCtD
Diatrizoate—Pulmonary embolism—Capecitabine—esophageal cancer	0.00816	0.00816	CcSEcCtD
Diatrizoate—Skin exfoliation—Capecitabine—esophageal cancer	0.00779	0.00779	CcSEcCtD
Diatrizoate—Face oedema—Cisplatin—esophageal cancer	0.00775	0.00775	CcSEcCtD
Diatrizoate—Necrosis—Methotrexate—esophageal cancer	0.00774	0.00774	CcSEcCtD
Diatrizoate—Blood creatinine increased—Cisplatin—esophageal cancer	0.00753	0.00753	CcSEcCtD
Diatrizoate—Petechiae—Methotrexate—esophageal cancer	0.00738	0.00738	CcSEcCtD
Diatrizoate—Cramp muscle—Cisplatin—esophageal cancer	0.00723	0.00723	CcSEcCtD
Diatrizoate—Speech disorder—Methotrexate—esophageal cancer	0.00706	0.00706	CcSEcCtD
Diatrizoate—Extravasation—Methotrexate—esophageal cancer	0.00696	0.00696	CcSEcCtD
Diatrizoate—Thrombophlebitis—Capecitabine—esophageal cancer	0.00684	0.00684	CcSEcCtD
Diatrizoate—Swelling—Capecitabine—esophageal cancer	0.00671	0.00671	CcSEcCtD
Diatrizoate—Oliguria—Methotrexate—esophageal cancer	0.00659	0.00659	CcSEcCtD
Diatrizoate—Renal failure acute—Capecitabine—esophageal cancer	0.00641	0.00641	CcSEcCtD
Diatrizoate—Amnesia—Capecitabine—esophageal cancer	0.0063	0.0063	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Cisplatin—esophageal cancer	0.0061	0.0061	CcSEcCtD
Diatrizoate—Renal failure—Cisplatin—esophageal cancer	0.00608	0.00608	CcSEcCtD
Diatrizoate—Pulmonary embolism—Methotrexate—esophageal cancer	0.00607	0.00607	CcSEcCtD
Diatrizoate—Myocardial infarction—Cisplatin—esophageal cancer	0.00607	0.00607	CcSEcCtD
Diatrizoate—Conjunctivitis—Cisplatin—esophageal cancer	0.00602	0.00602	CcSEcCtD
Diatrizoate—Skin exfoliation—Methotrexate—esophageal cancer	0.0058	0.0058	CcSEcCtD
Diatrizoate—Face oedema—Capecitabine—esophageal cancer	0.00572	0.00572	CcSEcCtD
Diatrizoate—Cardiac arrest—Capecitabine—esophageal cancer	0.00563	0.00563	CcSEcCtD
Diatrizoate—Coma—Methotrexate—esophageal cancer	0.00555	0.00555	CcSEcCtD
Diatrizoate—Blood creatinine increased—Capecitabine—esophageal cancer	0.00555	0.00555	CcSEcCtD
Diatrizoate—Pulmonary oedema—Methotrexate—esophageal cancer	0.0054	0.0054	CcSEcCtD
Diatrizoate—Flushing—Cisplatin—esophageal cancer	0.00516	0.00516	CcSEcCtD
Diatrizoate—Asthma—Capecitabine—esophageal cancer	0.00512	0.00512	CcSEcCtD
Diatrizoate—Thrombophlebitis—Methotrexate—esophageal cancer	0.00509	0.00509	CcSEcCtD
Diatrizoate—Bronchospasm—Capecitabine—esophageal cancer	0.00503	0.00503	CcSEcCtD
Diatrizoate—Arrhythmia—Cisplatin—esophageal cancer	0.00496	0.00496	CcSEcCtD
Diatrizoate—Erythema—Cisplatin—esophageal cancer	0.00484	0.00484	CcSEcCtD
Diatrizoate—Neutropenia—Capecitabine—esophageal cancer	0.00479	0.00479	CcSEcCtD
Diatrizoate—Renal failure acute—Methotrexate—esophageal cancer	0.00477	0.00477	CcSEcCtD
Diatrizoate—Muscle spasms—Cisplatin—esophageal cancer	0.00465	0.00465	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00455	0.00455	CcSEcCtD
Diatrizoate—Tremor—Cisplatin—esophageal cancer	0.00453	0.00453	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Capecitabine—esophageal cancer	0.0045	0.0045	CcSEcCtD
Diatrizoate—Renal failure—Capecitabine—esophageal cancer	0.00449	0.00449	CcSEcCtD
Diatrizoate—Myocardial infarction—Capecitabine—esophageal cancer	0.00447	0.00447	CcSEcCtD
Diatrizoate—Anaemia—Cisplatin—esophageal cancer	0.00447	0.00447	CcSEcCtD
Diatrizoate—Conjunctivitis—Capecitabine—esophageal cancer	0.00444	0.00444	CcSEcCtD
Diatrizoate—Haematuria—Capecitabine—esophageal cancer	0.00435	0.00435	CcSEcCtD
Diatrizoate—Leukopenia—Cisplatin—esophageal cancer	0.00433	0.00433	CcSEcCtD
Diatrizoate—Convulsion—Cisplatin—esophageal cancer	0.00419	0.00419	CcSEcCtD
Diatrizoate—Haemoglobin—Capecitabine—esophageal cancer	0.00412	0.00412	CcSEcCtD
Diatrizoate—Rhinitis—Capecitabine—esophageal cancer	0.00411	0.00411	CcSEcCtD
Diatrizoate—Haemorrhage—Capecitabine—esophageal cancer	0.0041	0.0041	CcSEcCtD
Diatrizoate—Hypoaesthesia—Capecitabine—esophageal cancer	0.00408	0.00408	CcSEcCtD
Diatrizoate—Anaphylactic shock—Cisplatin—esophageal cancer	0.00395	0.00395	CcSEcCtD
Diatrizoate—Oedema—Cisplatin—esophageal cancer	0.00395	0.00395	CcSEcCtD
Diatrizoate—Infection—Cisplatin—esophageal cancer	0.00392	0.00392	CcSEcCtD
Diatrizoate—Thrombocytopenia—Cisplatin—esophageal cancer	0.00387	0.00387	CcSEcCtD
Diatrizoate—Tachycardia—Cisplatin—esophageal cancer	0.00385	0.00385	CcSEcCtD
Diatrizoate—Hyperhidrosis—Cisplatin—esophageal cancer	0.00382	0.00382	CcSEcCtD
Diatrizoate—Asthma—Methotrexate—esophageal cancer	0.00381	0.00381	CcSEcCtD
Diatrizoate—Flushing—Capecitabine—esophageal cancer	0.0038	0.0038	CcSEcCtD
Diatrizoate—Hypotension—Cisplatin—esophageal cancer	0.00369	0.00369	CcSEcCtD
Diatrizoate—Chills—Capecitabine—esophageal cancer	0.00368	0.00368	CcSEcCtD
Diatrizoate—Arrhythmia—Capecitabine—esophageal cancer	0.00366	0.00366	CcSEcCtD
Diatrizoate—Erythema—Capecitabine—esophageal cancer	0.00357	0.00357	CcSEcCtD
Diatrizoate—Neutropenia—Methotrexate—esophageal cancer	0.00356	0.00356	CcSEcCtD
Diatrizoate—Paraesthesia—Cisplatin—esophageal cancer	0.00354	0.00354	CcSEcCtD
Diatrizoate—Dyspnoea—Cisplatin—esophageal cancer	0.00352	0.00352	CcSEcCtD
Diatrizoate—Dysgeusia—Capecitabine—esophageal cancer	0.00349	0.00349	CcSEcCtD
Diatrizoate—Muscle spasms—Capecitabine—esophageal cancer	0.00343	0.00343	CcSEcCtD
Diatrizoate—Pain—Cisplatin—esophageal cancer	0.00338	0.00338	CcSEcCtD
Diatrizoate—Tremor—Capecitabine—esophageal cancer	0.00334	0.00334	CcSEcCtD
Diatrizoate—Renal failure—Methotrexate—esophageal cancer	0.00334	0.00334	CcSEcCtD
Diatrizoate—Conjunctivitis—Methotrexate—esophageal cancer	0.0033	0.0033	CcSEcCtD
Diatrizoate—Anaemia—Capecitabine—esophageal cancer	0.0033	0.0033	CcSEcCtD
Diatrizoate—Sweating—Methotrexate—esophageal cancer	0.00326	0.00326	CcSEcCtD
Diatrizoate—Feeling abnormal—Cisplatin—esophageal cancer	0.00325	0.00325	CcSEcCtD
Diatrizoate—Haematuria—Methotrexate—esophageal cancer	0.00324	0.00324	CcSEcCtD
Diatrizoate—Leukopenia—Capecitabine—esophageal cancer	0.00319	0.00319	CcSEcCtD
Diatrizoate—Loss of consciousness—Capecitabine—esophageal cancer	0.00313	0.00313	CcSEcCtD
Diatrizoate—Body temperature increased—Cisplatin—esophageal cancer	0.00312	0.00312	CcSEcCtD
Diatrizoate—Cough—Capecitabine—esophageal cancer	0.00311	0.00311	CcSEcCtD
Diatrizoate—Hypertension—Capecitabine—esophageal cancer	0.00308	0.00308	CcSEcCtD
Diatrizoate—Haemoglobin—Methotrexate—esophageal cancer	0.00306	0.00306	CcSEcCtD
Diatrizoate—Haemorrhage—Methotrexate—esophageal cancer	0.00305	0.00305	CcSEcCtD
Diatrizoate—Chest pain—Capecitabine—esophageal cancer	0.00304	0.00304	CcSEcCtD
Diatrizoate—Confusional state—Capecitabine—esophageal cancer	0.00293	0.00293	CcSEcCtD
Diatrizoate—Oedema—Capecitabine—esophageal cancer	0.00291	0.00291	CcSEcCtD
Diatrizoate—Infection—Capecitabine—esophageal cancer	0.00289	0.00289	CcSEcCtD
Diatrizoate—Shock—Capecitabine—esophageal cancer	0.00286	0.00286	CcSEcCtD
Diatrizoate—Thrombocytopenia—Capecitabine—esophageal cancer	0.00285	0.00285	CcSEcCtD
Diatrizoate—Tachycardia—Capecitabine—esophageal cancer	0.00284	0.00284	CcSEcCtD
Diatrizoate—Asthenia—Cisplatin—esophageal cancer	0.00283	0.00283	CcSEcCtD
Diatrizoate—Hyperhidrosis—Capecitabine—esophageal cancer	0.00281	0.00281	CcSEcCtD
Diatrizoate—Chills—Methotrexate—esophageal cancer	0.00274	0.00274	CcSEcCtD
Diatrizoate—Hypotension—Capecitabine—esophageal cancer	0.00272	0.00272	CcSEcCtD
Diatrizoate—Diarrhoea—Cisplatin—esophageal cancer	0.0027	0.0027	CcSEcCtD
Diatrizoate—Erythema—Methotrexate—esophageal cancer	0.00265	0.00265	CcSEcCtD
Diatrizoate—Paraesthesia—Capecitabine—esophageal cancer	0.00261	0.00261	CcSEcCtD
Diatrizoate—Dysgeusia—Methotrexate—esophageal cancer	0.0026	0.0026	CcSEcCtD
Diatrizoate—Dyspnoea—Capecitabine—esophageal cancer	0.00259	0.00259	CcSEcCtD
Diatrizoate—Vomiting—Cisplatin—esophageal cancer	0.00251	0.00251	CcSEcCtD
Diatrizoate—Rash—Cisplatin—esophageal cancer	0.00249	0.00249	CcSEcCtD
Diatrizoate—Pain—Capecitabine—esophageal cancer	0.00249	0.00249	CcSEcCtD
Diatrizoate—Dermatitis—Cisplatin—esophageal cancer	0.00249	0.00249	CcSEcCtD
Diatrizoate—Anaemia—Methotrexate—esophageal cancer	0.00245	0.00245	CcSEcCtD
Diatrizoate—Feeling abnormal—Capecitabine—esophageal cancer	0.0024	0.0024	CcSEcCtD
Diatrizoate—Leukopenia—Methotrexate—esophageal cancer	0.00238	0.00238	CcSEcCtD
Diatrizoate—Nausea—Cisplatin—esophageal cancer	0.00235	0.00235	CcSEcCtD
Diatrizoate—Cough—Methotrexate—esophageal cancer	0.00232	0.00232	CcSEcCtD
Diatrizoate—Urticaria—Capecitabine—esophageal cancer	0.00231	0.00231	CcSEcCtD
Diatrizoate—Body temperature increased—Capecitabine—esophageal cancer	0.0023	0.0023	CcSEcCtD
Diatrizoate—Convulsion—Methotrexate—esophageal cancer	0.0023	0.0023	CcSEcCtD
Diatrizoate—Chest pain—Methotrexate—esophageal cancer	0.00226	0.00226	CcSEcCtD
Diatrizoate—Confusional state—Methotrexate—esophageal cancer	0.00218	0.00218	CcSEcCtD
Diatrizoate—Anaphylactic shock—Methotrexate—esophageal cancer	0.00217	0.00217	CcSEcCtD
Diatrizoate—Infection—Methotrexate—esophageal cancer	0.00215	0.00215	CcSEcCtD
Diatrizoate—Thrombocytopenia—Methotrexate—esophageal cancer	0.00212	0.00212	CcSEcCtD
Diatrizoate—Hyperhidrosis—Methotrexate—esophageal cancer	0.00209	0.00209	CcSEcCtD
Diatrizoate—Asthenia—Capecitabine—esophageal cancer	0.00209	0.00209	CcSEcCtD
Diatrizoate—Pruritus—Capecitabine—esophageal cancer	0.00206	0.00206	CcSEcCtD
Diatrizoate—Hypotension—Methotrexate—esophageal cancer	0.00202	0.00202	CcSEcCtD
Diatrizoate—Diarrhoea—Capecitabine—esophageal cancer	0.00199	0.00199	CcSEcCtD
Diatrizoate—Paraesthesia—Methotrexate—esophageal cancer	0.00195	0.00195	CcSEcCtD
Diatrizoate—Dyspnoea—Methotrexate—esophageal cancer	0.00193	0.00193	CcSEcCtD
Diatrizoate—Dizziness—Capecitabine—esophageal cancer	0.00192	0.00192	CcSEcCtD
Diatrizoate—Pain—Methotrexate—esophageal cancer	0.00185	0.00185	CcSEcCtD
Diatrizoate—Vomiting—Capecitabine—esophageal cancer	0.00185	0.00185	CcSEcCtD
Diatrizoate—Rash—Capecitabine—esophageal cancer	0.00183	0.00183	CcSEcCtD
Diatrizoate—Dermatitis—Capecitabine—esophageal cancer	0.00183	0.00183	CcSEcCtD
Diatrizoate—Headache—Capecitabine—esophageal cancer	0.00182	0.00182	CcSEcCtD
Diatrizoate—Feeling abnormal—Methotrexate—esophageal cancer	0.00179	0.00179	CcSEcCtD
Diatrizoate—Nausea—Capecitabine—esophageal cancer	0.00173	0.00173	CcSEcCtD
Diatrizoate—Urticaria—Methotrexate—esophageal cancer	0.00172	0.00172	CcSEcCtD
Diatrizoate—Body temperature increased—Methotrexate—esophageal cancer	0.00171	0.00171	CcSEcCtD
Diatrizoate—Asthenia—Methotrexate—esophageal cancer	0.00155	0.00155	CcSEcCtD
Diatrizoate—Pruritus—Methotrexate—esophageal cancer	0.00153	0.00153	CcSEcCtD
Diatrizoate—Diarrhoea—Methotrexate—esophageal cancer	0.00148	0.00148	CcSEcCtD
Diatrizoate—Dizziness—Methotrexate—esophageal cancer	0.00143	0.00143	CcSEcCtD
Diatrizoate—Vomiting—Methotrexate—esophageal cancer	0.00138	0.00138	CcSEcCtD
Diatrizoate—Rash—Methotrexate—esophageal cancer	0.00137	0.00137	CcSEcCtD
Diatrizoate—Dermatitis—Methotrexate—esophageal cancer	0.00136	0.00136	CcSEcCtD
Diatrizoate—Headache—Methotrexate—esophageal cancer	0.00136	0.00136	CcSEcCtD
Diatrizoate—Nausea—Methotrexate—esophageal cancer	0.00129	0.00129	CcSEcCtD
